Latest Breaking News On - Akebia therapeutics inc - Page 1 : comparemela.com

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesMercedes carrascoAkebia therapeutics incAkebia therapeuticsNasdaq listing rule

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Akebia Therapeutics, Inc. , a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted 4 newly-hired employees options to purchase an aggregate of 76,000 shares of Akebia's common stock on May 31,.

United kingdomUnited statesMercedes carrascoAkebia therapeutics incAkebia therapeuticsNasdaq listing rule

Analyzing Atea Pharmaceuticals (NASDAQ:AVIR) & Akebia Therapeutics (NASDAQ:AKBA)

Akebia Therapeutics (NASDAQ:AKBA – Get Free Report) and Atea Pharmaceuticals (NASDAQ:AVIR – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, risk, earnings, profitability, institutional ownership, dividends and analyst recommendations. Earnings and Valuation This table compares Akebia […]

United kingdomUnited statesAkebia therapeutics incMitsubishi tanabe pharma corporationAtea pharmaceuticals incInternational gmbAtea pharmaceuticalsAkebia therapeuticsGet free reportAtea pharmaceuticalGiven akebia therapeuticJanssen pharmaceuticaAkebia therapeutics daily

Atea Pharmaceuticals (NASDAQ:AVIR) & Akebia Therapeutics (NASDAQ:AKBA) Financial Comparison

Akebia Therapeutics (NASDAQ:AKBA – Get Free Report) and Atea Pharmaceuticals (NASDAQ:AVIR – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, risk, profitability, valuation, dividends, institutional ownership and analyst recommendations. Analyst Recommendations This is a breakdown of […]

United statesUnited kingdomAkebia therapeutics incMitsubishi tanabe pharma corporationAtea pharmaceuticalsInternational gmbAtea pharmaceuticals incAkebia therapeuticsGet free reportGiven akebia therapeuticAtea pharmaceuticalJanssen pharmaceuticaAkebia therapeutics daily

Head-To-Head Comparison: Akebia Therapeutics (NASDAQ:AKBA) vs ProMIS Neurosciences (NASDAQ:PMN)

Akebia Therapeutics (NASDAQ:AKBA – Get Free Report) and ProMIS Neurosciences (NASDAQ:PMN – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, profitability, institutional ownership, earnings, dividends, risk and analyst recommendations. Institutional and Insider Ownership 33.9% of Akebia […]

United statesUnited kingdomMitsubishi tanabe pharma corporationAmorfix life sciences ltdPromis neurosciences incAkebia therapeutics incAkebia therapeuticsGet free reportJanssen pharmaceuticaCollective coordinatesAmorfix life sciencesAkebia therapeutics daily